- Gissmann L, Wolnik L, Ikenberg H, et al. Human papillomavirus types 6 and 11 DNA sequences in genital and laryngeal papillomas and in some cervical cancers. Proc Natl Acad Sd USA 1983; 80: 560-3.
- Barrasso R, Coupex F, Ionesco M, de Brus J. Human papilloma viruses and cervical intraepithelial neoplasia: the role of colposcopy. Gynecol Oncol 1987;27:1997-2007.
- Pfister H. Human papillomavirus and genital cancer. Adv Cancer Res 1987;48: 113-47.
- Bauer HM, Ting Y, Greer CE, et al. Genital human papillomavirus infection in female university students as determined by a PCR-based method [see comments]. J Am Med Assoc 1991; 265: 472-7.
- Hildesheim A, Schiffman MH, Gravitt PE, et al. Persistence of typespecific human papillomavirus infection among cytologically normal women. 1 Infect Dis 1994; 169: 235-40.
- Carter JJ, Hagensee MB, Lee SK, et al. Use of HPV 1 capsids produced by recombinant vaccinia viruses in an ELISA to detect serum antibodies in people with foot warts. Virology 1994; 199: 284-91.
- Christensen ND, Kreider JW, Shah KV, Rando RF. Detection of human serum antibodies that neutralize infectious human papillomavirus type 11 virions. J Gen Viral 1992; 73; 1261-7.
- Lawton G, Thomas S1 Schonrock J, et al. Human papillomaviruses in normal oral mucosa: a comparison of methods for sample collection. J Oral Pathol Med 1992: 21(6); 265-9.
- Gravitt PE, Manos MM. Polymerase chain reaction based methods for the detection of human papillomavirus DNA. IARC Sd Publ 1992; 119: 121-3.
- Park DS, Selvey LA, Kelsall SR, Frazer IH. Human papillomavirus type 16 E6, E7 and Ll and type 18 E7 proteins produced by recombinant baculoviruses. J Virol Methods 1993; 45: 303-18.
- Qi YM, Peng SW, Hengst K, et al. Epithelial cells display separate receptors for papillomavirus VLPs and for soluble Ll capsid protein. Virology 1996; 216: 35-45.
- Peng SW, Frazer IH, Fernando GJ, Zhou J. Papillomavirus virus-like particles can deliver defined CTL epitopes to the MHC class I pathway. Virology 1998; 240: 147-57.
- Kulski JK, Sadleir JW, Kelsall SR, et al. Type-specific and genotype cross reactive B epitopes of the Ll protein of HPV16 defined by a panel of monoclonal antibodies. Virology 1998; 243: 275-82.
- Sun XY, Frazer I, Muller M, et al. Sequences required for the nuclear targeting and accumulation of human papillomavirus type 66 L2 protein. Virology 1995; 213: 321-7.
- Christensen ND, Kirnbauer R, Schiller JT, et al. Human papillomavirus types 6 and 11 have antigenically distinct strongly immunogenic conformationally dependent neutralizing epitopes. Virology 1994b; 205: 329-35.
- Christensen ND, Dillner J, Eklund C, et al. Surface conformational and linear epitopes on HPV-16 and HPV-18 Ll virus-like particles as defined by monoclonal antibodies. Virology 1996; 223: 174-84.
- Volpers C, Unckell F, Schirmacher P, et al. Binding and internalization of human papillomavirus type 33 virus-like particles by eukaryotic cells. J Virol 1995; 69: 3258-64.
- Christensen ND, Hopfl R, DiAngelo SL, et al. Assembled baculovirusexpressed human papillomavirus type 11 L1 capsid protein virus-like particles are recognized by neutralizing monoclonal antibodies and induce high titres of neutralizing antibodies. J Gen Virol 1994; 75: 2271-6.
- Hagensee ME, Olson NH, Baker TS, Galloway DA. Three-dimensional structure of vaccinia virus-produced human papillomavirus type 1 capsids. J Virol 1994; 68: 4503-5.
- Heim K, Christensen ND, Hoepfl R, et al. Serum IgG, IgM and IgA reactivity of human papillomavirus types 11 and 6 virus-like particles in different gynecologic patient groups. J Infect Dis 1995; 172: 395-402.
- Carter JJ, Koutsky LA, Wipf GC, et al. The natural history of human papillomavirus type 16 capsid antibodies among a cohort of university women. J Infect Dis 1996; 174: 927-36.
- Greer CE, Wheeler CM, Ladner MB, et al. Human papillomavirus (HPV) type distribution and serological response to HPV type 6 viruslike particles in patients with genital warts. J Clin Microbiol 1995: 33(8): 2058-63.
- Carter JJ, Hagensee M, Taflin MC, et al. HPV-I capsids expressed in vitro detect human serum antibodies associated with foot warts. Virology 1993; 195: 456-62.
- Bonnez W, Da Rin C, Rose RC, Reichman RC. Use of human papillomavirus type 11 virions in an ELISA to detect specific antibodies in humans with condylomata acuminata. J Gen Virol 1991 ; 72: 1343-7.
- Smith LH. Foster C. Hitchcock ME, et al. Titration of HPV-H infectivity and antibody neutralization can be measured in vitro. J Invest Dermatol 1995; 105: 438-44.
- Roden RB, Greenstone HL, Kirnbauer R, et al. Assessment of the serological relatedness of genital human papillomaviruses by hemagglutination inhibition. J Virol 1996; 70: 3298-301.
- Roden RB, Greenstone HL, Kirnbauer R, et al. In vitro generation and type-specific neutralisation of a human papillomavirus type 16 virion pseudotype. J Virol 1996; 70:5875-83.
- Choose new content alerts to be informed about new research of interest to you
- Easy remote access to your institution's subscriptions on any device, from any location
- Save your searches and schedule alerts to send you new results
- Export your search results into a .csv file to support your research